By From August 1st, the Swiss Medical Cannabis Act will be officially enforced. The news is the result of an amendment to the Swiss Drug Law enacted by the Federal Parliament (also known as the Swiss Parliament) almost a year and a half ago. The ban on medical cannabis was lifted by the Federal Council in June.
Beginning August 1, medical cannabis patients will be able to receive prescriptions directly from practitioners without the need for permission from the Federal Office of Public Health (FOPH).The amendment also permits the export of medical cannabis as long as the licensed company seeks approval from Swiss pharmaceuticalsI am in charge of “approval and supervision of therapeutic drugs”.
In a press release, the Federal Council stated that increased demand prompted change. In this translation, “BAG” is an abbreviation for. Bundesamt für GesundheitOr the Federal Office of Public Health.
“Until now, medical cannabis was not allowed to be cultivated, imported, or processed into preparations without exceptional permission. Treatment of patients with licensed cannabis drugs is BAG. Without exceptional permission from, it was only possible in legitimate cases, “translated the Federal Council. press release.. “The demand for such permits has increased in recent years. This is an administratively complex delayed treatment and no longer addresses the exceptional character stipulated by the Narcotics Act. Therefore, the Federal Council , Submitted to Congress an amendment to the law to lift the ban on medical cannabis passed in March 2021. Such drugs still require drug prescriptions. “
Currently, Switzerland only allows CBD products with a THC of less than 1%, and recreational cannabis remains illegal. However, Switzerland plans to launch a cannabis pilot program in Basel, which is located in the northern part of the country. University of Basel, its psychiatric clinic, and local government..
Program allows About 400 people According to the announcement in April 2022, recreational cannabis will be purchased in September. During the two and a half years, the participants I will answer the question About physical and mental health.For use in this study, cannabis is provided by Pure production..
In addition, a study called “Züri Can-Responsible Cannabis” is approaching final approval with the goal of investigating the effectiveness of medical cannabis. This study was first published in September 2021. June 28, confirmed by researchers They sent the application to the FOPH and the State Institutional Review Board.There is currently a waiting list of people interested in this survey, in total 2,100 participants allowed..
Other recent studies confirm that demand for cannabis continues to grow. A study conducted by the Faculty of Sociology of the University of Geneva and a consulting firm called EBP Switzerland.Economic impact of current and alternative regulation in SwitzerlandFound that the legalization of cannabis was valued at $ 1.03 billion and could bring 4,400 jobs to the country. Adrian Gschwend, Head of Policy and Implementation at the FOPH, explained the critical timing of this data. “The study will be done at the right time, as the National Assembly’s Committee on Social and Healthcare Issues has recently begun legislation on the legalization of cannabis,” Gushwent said. MyScience.com.. “The results show that both the current illegal market and the liberal commercial market are costing the general public and making great profits for individuals. Therefore, protection and health protection measures for children and adolescents. You need a well-regulated market that guarantees both.[s].. “
